Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Cigna Group Yönetim
Yönetim kriter kontrolleri 3/4
Cigna Group's CEO'su David Cordani, Jun2008 tarihinde atandı, in görev süresi 16.33 yıldır. in toplam yıllık tazminatı $ 21.05M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.1% maaş ve 92.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.22% ine doğrudan sahiptir ve bu hisseler $ 211.77M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.1 yıl ve 5.8 yıldır.
Anahtar bilgiler
David Cordani
İcra Kurulu Başkanı
US$21.0m
Toplam tazminat
| CEO maaş yüzdesi | 7.1% |
| CEO görev süresi | 16.3yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 4.1yrs |
| Yönetim Kurulu ortalama görev süresi | 5.8yrs |
Son yönetim güncellemeleri
Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18
Recent updates
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well
Oct 14Cigna: This Dividend Grower Could Be Worth Buying Now
Sep 26Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)
Sep 26Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Sep 19The Price Is Right For The Cigna Group (NYSE:CI)
Sep 08Cigna Group: Services Focus Leads To Outperformance
Jul 29Cigna: Game Over For PBMs?
Jul 12Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet
Jun 14Cigna: Will Benefit From Lower Medicaid Enrollments
Jun 11The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing
May 27Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now
May 13Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture
May 09Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why
Apr 09Returns Are Gaining Momentum At Cigna Group (NYSE:CI)
Apr 05Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018
Apr 01Cigna: Trimming The Fat And Staying Focused
Mar 05Cigna: Big Buybacks And Total Return Potential
Feb 26Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40
Feb 05Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap
Jan 29We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Jan 25Why Dividend Growth Investors Should Buy Cigna
Jan 18It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)
Jan 09Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital
Dec 25Cigna: Sentiment And Fundamentals On Their Side
Dec 21Cigna's Merger Fumble: A Festive Financial Rebound
Dec 11Humana And Cigna Topple On Rumors Of An Unlikely Union
Nov 30Cigna Delivering Growth At A Great Price
Nov 13Cigna: Too Cheap To Ignore
Oct 24We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Oct 06Cigna: Buy Rating Driven By Undervaluation & Revenue Growth
Oct 01Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return
Sep 21Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape
Sep 14Cigna Group: Weaker Than Peers But Still A Buy
Aug 27Cigna: Buy During The Next Correction (Technical Analysis)
Aug 08Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet
Jul 02Cigna: Buy While It's Still Cheap And Not Loved
Jun 29If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity
Jun 18Cigna: Buy This Value Gem Before It Bounces Back
Jun 12Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture
Jun 04Cigna: Many Reasons To Invest
May 29An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued
May 21Is Cigna Group (NYSE:CI) A Risky Investment?
Mar 24CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$4b |
| Mar 31 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$7b |
| Mar 31 2023 | n/a | n/a | US$7b |
| Dec 31 2022 | US$21m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$7b |
| Jun 30 2022 | n/a | n/a | US$5b |
| Mar 31 2022 | n/a | n/a | US$5b |
| Dec 31 2021 | US$20m | US$2m | US$5b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$8b |
| Mar 31 2021 | n/a | n/a | US$8b |
| Dec 31 2020 | US$20m | US$2m | US$8b |
| Sep 30 2020 | n/a | n/a | US$5b |
| Jun 30 2020 | n/a | n/a | US$5b |
| Mar 31 2020 | n/a | n/a | US$5b |
| Dec 31 2019 | US$19m | US$2m | US$5b |
| Sep 30 2019 | n/a | n/a | US$4b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$3b |
| Dec 31 2018 | US$19m | US$1m | US$3b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$3b |
| Mar 31 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$18m | US$1m | US$2b |
Tazminat ve Piyasa: David 'nin toplam tazminatı ($USD 21.05M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 13.04M ).
Tazminat ve Kazançlar: David 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
David Cordani (59 yo)
16.3yrs
Görev süresi
US$21,047,255
Tazminat
Mr. David Michael Cordani serves as Chair of the Board at The Cigna Group (formerly known as Cigna Corporation) since January 01, 2022. He has been the Chief Executive Officer and President of The Cigna Gr...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 16.3yrs | US$21.05m | 0.22% $ 215.8m | |
| Executive VP | 3.8yrs | US$7.79m | 0.015% $ 14.8m | |
| Executive VP & Global Chief Information Officer | 4.1yrs | US$5.27m | 0.0060% $ 6.0m | |
| Executive VP | 13.3yrs | US$5.21m | 0.010% $ 10.1m | |
| Executive Vice President of Enterprise Strategy | less than a year | US$8.93m | 0.020% $ 19.8m | |
| Chief Accounting Officer | less than a year | Veri yok | 0.00043% $ 424.5k | |
| Senior VP & Head of Investor Relations | 2.8yrs | Veri yok | Veri yok | |
| Executive VP | no data | Veri yok | Veri yok | |
| President of International MArkets & President of International Health Cigna Healthcare | 10.3yrs | US$3.53m | 0.015% $ 14.4m | |
| President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) Businesses | 1.3yrs | Veri yok | Veri yok | |
| Head of Strategy & Global Business Development for Cigna International Markets | 4.6yrs | Veri yok | Veri yok | |
| President and GM of Florida & Caribbean Markets | 11.1yrs | Veri yok | Veri yok |
4.1yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim: CI 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.1 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 15yrs | US$21.05m | 0.22% $ 215.8m | |
| Independent Director | 19.7yrs | US$337.78k | 0.0053% $ 5.2m | |
| Independent Director | 13.3yrs | US$335.28k | 0.013% $ 12.5m | |
| Lead Independent Director | 17.5yrs | US$360.28k | 0.0015% $ 1.5m | |
| Independent Director | 4.3yrs | US$337.78k | 0.0014% $ 1.4m | |
| Independent Director | 5.8yrs | US$335.28k | 0.0020% $ 1.9m | |
| Independent Director | 5.8yrs | US$310.28k | 0.0063% $ 6.2m | |
| Independent Director | 5.8yrs | US$310.28k | 0.0020% $ 1.9m | |
| Independent Director | 1.3yrs | US$248.50k | 0.00042% $ 414.6k | |
| Independent Director | 5.8yrs | US$335.28k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$310.28k | 0.0011% $ 1.1m | |
| Independent Director | 3.1yrs | US$310.28k | 0.00098% $ 967.4k |
5.8yrs
Ortalama Görev Süresi
62.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: CI 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).